FiercePharmaOriginal article
{"a":[{"_":"GSK CEO targets $2.5B in cost savings from mature products, procurement, supply chain","$":{"href":"/pharma/gsk-ceo-targets-25b-cost-savings-mature-products-procurement-supply-chain","hreflang":"en"}}]}
Positive
AI Analysis
Summary
GSK CEO Luke Miels announced a three-year restructuring plan targeting $2.5 billion in annual cost savings by 2029, primarily from mature products, procurement, and supply chain optimization.
Financial Highlights
Guidance
$2.5 billion in annual cost savings by 2029
Importance:4/10
Sentiment:
0.30
cost_reductionrestructuringoperational_efficiencymanagement
Related Companies
Read the original article
Published by FiercePharma on July 28, 2026 9:07 AM
